Delivery Order SPE2DB20D7066-SPE2DB25FC2KT

Award Date 2/27/25
Potential Completion Date 2/28/25
Potential Value $7.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,455.63, is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of January 31, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,088.44 firm fixed-price contract is for the supply of 4565047394 Budesonide-Formoterol 160-4.5 10.2GM, a medical product used in the treatment of respiratory conditions. The contract has an ultimate completion date of July 2, 2024 and was awarded on July 1, 2024. This delivery order is part of a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,210.56, is for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a respiratory medication, with a final delivery date of December 12, 2023. The contract is structured as a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen also holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,199.76 firm fixed-price contract is for the supply of the drug Budesonide-Formoterol 160-4.5 10.2GM. The award does not have a set-aside designation, indicating open competition. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,399.56 contract is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a medication used for the treatment of respiratory conditions. The contract has a period of performance through December 11, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,187.61 firm fixed-price contract is for the delivery of budesonide-formoterol 160-4.5 10.2 gram medical supplies, with a completion date of May 9, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, and has a total ceiling value of $16,773.40. The contract is a firm fixed-price delivery order with a performance period ending on February 5, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,310.40 firm fixed-price delivery order contract is for the supply of the pharmaceutical product Budesonide-Formoterol 160-4.5 10.2GM. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,807.84 Firm Fixed Price contract is for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a respiratory medication. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,803.07 firm fixed-price contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a completion date of December 19, 2024. This award is not designated as a set-aside contract. The contract is part of a larger $999,999,999 Indefinite Delivery...
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB25FC2KT
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,753.20 firm fixed-price contract is for the supply of budesonide-formoterol 160-4.5 10.2GM, a medical product, with a completion date of February 28, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/1/25, 2:59 AM